VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
DLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DLBDolby Laboratories, Inc.
$58.03$5.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. DLB
  4. Financial Ratios

Dolby Laboratories, Inc. (DLB) Financial Ratios

Latest Ratios: P/E Ratio 22.1x · EV/EBITDA 13.4x · ROE 10.0%. (2003–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

DLB Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$5.5B$7.1B$7.4B$7.7B$6.6B$9.7B$6.7B$6.7B$7.5B$5.9B$5.6B
Enterprise Value$4.9B$6.4B$6.8B$7.0B$6.1B$8.5B$5.7B$5.9B$6.6B$5.3B$5.0B
P/E Ratio →22.1527.6328.1140.4435.9931.1328.8826.1461.3829.5029.99
P/S Ratio4.095.235.785.955.307.555.765.377.105.495.42
P/B Ratio2.152.682.963.262.953.712.742.883.412.772.81
P/FCF12.8316.4024.7622.9725.6424.6024.3431.1528.0521.7740.21
P/OCF11.6914.9422.4921.0720.8621.6119.4620.3621.2515.7315.44

P/E links to full P/E history page with 30-year chart

DLB EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—4.745.365.364.846.644.904.726.224.914.91
EV / EBITDA13.3617.5919.4019.4418.9119.5018.2715.4824.8215.3515.84
EV / EBIT18.3322.8421.8527.8628.1824.0123.7420.7833.4120.6821.37
EV / FCF—14.8622.9720.6923.4121.6520.7127.3924.5819.4436.45

DLB Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin88.1%88.1%89.0%88.3%88.7%89.9%87.4%87.0%87.9%89.1%89.4%
Operating Margin19.6%19.6%20.8%20.2%17.3%26.6%19.0%23.6%17.4%24.2%22.7%
Net Profit Margin18.9%18.9%20.6%15.4%14.7%24.2%19.9%20.5%4.0%18.7%18.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE10.0%10.0%10.8%8.7%7.6%12.3%9.7%11.3%1.9%9.8%9.8%
ROA8.0%8.0%8.5%7.0%6.3%10.2%8.0%9.0%1.5%8.3%8.4%
ROIC10.1%10.1%11.2%12.0%10.5%17.7%11.2%15.9%9.9%13.2%12.8%
ROCE9.6%9.6%10.0%10.5%8.3%12.4%8.5%11.5%7.5%11.9%11.6%

DLB Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.010.010.020.020.020.030.03————
Debt / EBITDA0.110.110.130.140.160.170.26————
Net Debt / Equity—-0.25-0.21-0.32-0.26-0.45-0.41-0.35-0.42-0.30-0.26
Net Debt / EBITDA-1.82-1.82-1.51-2.14-1.80-2.66-3.21-2.13-3.50-1.83-1.63
Debt / FCF—-1.54-1.79-2.28-2.23-2.95-3.63-3.76-3.47-2.32-3.76
Interest Coverage———————————

Net cash position: cash ($702M) exceeds total debt ($39M)

DLB Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.173.172.863.524.725.585.794.504.784.123.57
Quick Ratio3.103.102.783.444.645.545.704.404.694.013.49
Cash Ratio1.601.601.382.272.954.034.223.014.053.593.01
Asset Turnover—0.420.410.430.460.410.400.440.370.430.44
Inventory Turnover5.265.264.174.286.0011.865.734.984.874.726.66
Days Sales Outstanding—138.49146.99124.79122.18118.20107.35113.34115.7825.7227.39

DLB Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield2.2%1.8%1.6%1.3%1.5%0.9%1.3%1.2%0.9%1.0%0.9%
Payout Ratio49.6%49.6%43.8%51.5%54.4%28.7%38.3%30.4%158.5%28.3%26.0%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield4.5%3.6%3.6%2.5%2.8%3.2%3.5%3.8%1.6%3.4%3.3%
FCF Yield7.8%6.1%4.0%4.4%3.9%4.1%4.1%3.2%3.6%4.6%2.5%
Buyback Yield2.9%2.3%2.7%2.3%8.5%2.9%2.9%5.4%2.3%2.0%2.1%
Total Shareholder Yield5.2%4.1%4.3%3.7%10.0%3.8%4.3%6.6%3.2%2.9%2.9%
Shares Outstanding—$97M$97M$98M$102M$105M$103M$105M$107M$103M$102M

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetFortress
Cash FlowStable
Top Statement Risk

AV1 codec adoption threat

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Gross Margin Stability Masks Operating Volatility

Gross margin held near 87% in Q3 2026, but operating margin swung to 12.5% from 29.1% in Q2, per reported figures, indicating cost control is the key variable.

The 86-90% gross margin range over ten quarters confirms the IP-centric model's pricing power, yet operating margin volatility (9.7% to 30.3%) suggests fixed costs are not always covered during revenue dips. The Q3 2026 operating margin of 12.5% is well below the 10-quarter average, implying that SG&A escalation and product mix shifts are pressuring profitability. Investors should monitor whether this is a one-off timing effect or a structural margin compression trend.

Return on Capital Remains Modest but Stable

ROIC averaged roughly 2.7% over the last ten quarters, with Q3 2026 at 1.4%, as per financial statements, reflecting a capital-light model with high cash balances.

Despite high gross margins, ROIC is low because the balance sheet carries significant cash and investments that earn minimal returns, diluting the return on total capital. The 10-quarter ROIC range of 1.1% to 4.7% indicates no clear compounding trend, suggesting that the company is not reinvesting at high incremental returns. This may imply that capital allocation is focused on returning cash to shareholders rather than pursuing high-ROIC growth opportunities.

Working Capital Cycle Lengthens on Receivables

Cash conversion cycle extended to 201 days in Q3 2026 from 175 days in Q2 2026, driven by DSO of 167 days, as reported in the latest quarterly data.

The CCC has trended upward over the past year, with DSO rising from 129 days in Q2 2024 to 167 days in Q3 2026, indicating slower collections from licensees. This may reflect the lagged royalty reporting typical of the licensing model, but the magnitude suggests potential strain in customer payment behavior. The company's strong liquidity position (current ratio 3.19) mitigates near-term risk, but the lengthening cycle warrants monitoring for cash flow timing distortions.

Minimal Leverage Provides Strategic Flexibility

Debt-to-equity stands at 0.02 with D/EBITDA of 0.75, as per the latest balance sheet, indicating negligible leverage and ample capacity to weather revenue volatility.

With total debt of only $47.5M against $2.6B equity, the company's balance sheet is a fortress, and interest coverage is effectively infinite. This low leverage suggests that the company is insulated from rising rate environments and can fund its dividend and buyback program without financial strain. However, the conservative capital structure may also indicate a lack of high-return internal investment opportunities, as reflected in the modest ROIC.

Liquidity Buffer Absorbs Royalty Timing Swings

Current ratio of 3.19 and quick ratio of 3.11 in Q3 2026, per reported data, provide a substantial cushion against lumpy royalty collections and potential revenue dips.

The liquidity position is robust, with cash and short-term investments covering nearly all current liabilities, and the company has no near-term debt maturities. This buffer is critical given the volatility in operating cash flow, which swung from a $90.5M inflow in Q3 2026 to a $72.1M outflow in Q2 2026. Even under a severe stress scenario, such as a prolonged consumer electronics downturn, the company appears well-positioned to maintain operations and shareholder returns.

P/E Misleads on Licensing Model Earnings

The trailing P/E of 24.91 overstates value because it includes volatile one-off items, while forward P/E of 14.88 better reflects normalized earnings, as per current valuation data.

The most commonly misapplied ratio for Dolby is the P/E, because reported earnings are subject to significant timing effects from royalty audits and stock-based compensation, which can distort the multiple. For instance, the Q3 2026 EPS miss of $0.69 versus $1.2 estimate suggests that trailing earnings may not be representative of sustainable earning power. Instead, investors should focus on EV/EBITDA (15.26) or P/FCF (14.43), which better capture the cash-generative nature of the licensing model and smooth out non-cash charges.

Download Financial Ratios Data

Includes 30+ ratios · 23 years · Updated daily

Consensus & Technical Research Suite
Open DLB Terminal

DLB Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

DLB — Frequently Asked Questions

Quick answers to the most common questions about buying DLB stock.

What is Dolby Laboratories, Inc.'s P/E ratio?

Dolby Laboratories, Inc.'s current P/E ratio is 22.1x. The historical average is 27.1x. This places it at the 33th percentile of its historical range.

What is Dolby Laboratories, Inc.'s EV/EBITDA?

Dolby Laboratories, Inc.'s current EV/EBITDA is 13.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.1x.

What is Dolby Laboratories, Inc.'s ROE?

Dolby Laboratories, Inc.'s return on equity (ROE) is 10.0%. The historical average is 14.5%.

Is DLB stock overvalued?

Based on historical data, Dolby Laboratories, Inc. is trading at a P/E of 22.1x. This is at the 33th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Dolby Laboratories, Inc.'s dividend yield?

Dolby Laboratories, Inc.'s current dividend yield is 2.24% with a payout ratio of 49.6%.

What are Dolby Laboratories, Inc.'s profit margins?

Dolby Laboratories, Inc. has 88.1% gross margin and 19.6% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Dolby Laboratories, Inc. have?

Dolby Laboratories, Inc.'s Debt/EBITDA ratio is 0.1x, indicating low leverage. A ratio below 2x is generally considered financially healthy.